Introduction
============

Bedside capillary or arterial blood glucose monitoring is mandatory for ICU patients under tight glycemic control. Point-of-care methods are based on glucose-oxidase (GO) or glucose-dehydrogenase (GD) enzymatic methods whereas the laboratory reference method is hexokinase for measuring the plasma glucose levels.

Methods
=======

In this prospective observational study, blood glucose was simultaneously measured on the Glucocard Arkray (GO, capillary), on the Accu-chek Inform Roche (GD, capillary and arterial) and on the Rapid-Lab 1265 Bayer (GO, arterial), and each value was compared with the reference laboratory result.

Results
=======

A total of 262 matched analyses were done in 60 patients. Biases are defined as the glucose laboratory value minus point-of-care value. The bias, 95% limits of agreement, and numbers of observed discrepancy (*d*) paired results \>20% and \>10% are reported in Table [1](#T1){ref-type="table"}.

  Point-of care method      Number of comparisons   Bias (mg/dl)   Agreement (mg/dl)   Number \>20%*d*(%)   Number \>10%*d*(%)
  ------------------------- ----------------------- -------------- ------------------- -------------------- --------------------
  Glucocard, GO capillary   262                     +8.5           ± 36                32 (12)              103 (39)
  Accu-chek, GD capillary   262                     -6.3           ± 37                40 (15)              123 (45)
  Rapid-Lab, GO arterial    262                     +5.3           ± 11                \(0\)                21 (8)
  Accu-chek, GD arterial    234                     -7.9           ± 17                17 (7)               67 (29)

Conclusion
==========

GO methods underestimate while GD methods overestimate all blood glucose levels as compared with plasma glucose levels measured by the reference method of hexokinase. Capillary methods have wider 95% limits of agreement than measures carried out on arterial blood.
